Zhao, C., Li, X., Mu, M., Quan, L., Yuan, H., Zheng, J., . . . Yu, J. FXR acts as a therapeutic target for ulcerative colitis via suppressing ferroptosis. BMC.
Chicago Style (17th ed.) CitationZhao, Chenye, Xiaopeng Li, Mingchao Mu, Liyong Quan, Hang Yuan, Jianbao Zheng, Wei Zhao, Xuejun Sun, and Junhui Yu. FXR Acts as a Therapeutic Target for Ulcerative Colitis via Suppressing Ferroptosis. BMC.
MLA (9th ed.) CitationZhao, Chenye, et al. FXR Acts as a Therapeutic Target for Ulcerative Colitis via Suppressing Ferroptosis. BMC.
Warning: These citations may not always be 100% accurate.